Biophytis (EPA:ALBPS) | Finanzwire

Basculer en Français

9478	Companies
185482	Keywords
117825	Articles
99322	Press releases

Home
Companies
Biophytis

BRIEF

published on 03/28/2025 at 22:05, 8 months 7 days ago

Biophytis Finalizes €2.6 Million Private Placement

Private Placement Biophytis Warrants New Shares Euronext Growth
REGULATED PRESS RELEASE

published on 03/28/2025 at 22:00, 8 months 7 days ago

Biophytis announces the settlement and delivery of its €2.6 million private placement
Biophytis announces the settlement and delivery of its €2.6 million private placement. New shares admitted for trading on Euronext Growth. Maxim Group LLC and Invest Securities involved in the transaction

Private Placement Biophytis Euronext Growth Maxim Group LLC Settlement
PRESS RELEASE

published on 03/28/2025 at 21:59, 8 months 7 days ago

Biophytis announces the settlement and delivery of its €2.6 million private placement
Biophytis settles €2.6 million private placement, issuing new shares and warrants. Company specializes in age-related disease treatments

Private Placement Biophytis Warrants New Shares Age-related Diseases
BRIEF

published on 03/26/2025 at 07:40, 8 months 10 days ago

Biophytis Completes €2.6 Million Private Placement

Private Placement Biophytis Trading Capital Increase Clinical Programs
REGULATED PRESS RELEASE

published on 03/26/2025 at 07:35, 8 months 10 days ago

Biophytis announces the successful completion of a €2,6 million private placement
Biophytis successfully completes €2.6M private placement, aiming to accelerate clinical programs and partnerships, strengthen corporate purposes, and extend cash runway

Private Placement Biophytis Biotechnology Fundraising Clinical Programs
BRIEF

published on 03/24/2025 at 07:35, 8 months 12 days ago

Biophytis Reveals New Preclinical Findings on Obesity Treatment

Biophytis Obesity Treatment GLP-1 Preclinical Results Muscle Strength
REGULATED PRESS RELEASE

published on 03/24/2025 at 07:30, 8 months 12 days ago

Biophytis announces new non-clinical data further supporting its mission to pioneer the restoration of mobility in patients with obesity
Biophytis announces new preclinical study results showing combination of BIO101 and GLP-1 restores muscle strength and mobility in obesity patients. The company aims to pioneer mobility restoration in obese patients

Biophytis Preclinical Study BIO101 Obesity GLP-1
BRIEF

published on 03/17/2025 at 07:05, 8 months 19 days ago

Biophytis Publishes Promising Sarcopenia Trial Results

Biophytis Clinical Trial Sarcopenia BIO101 Phase 2 Results
REGULATED PRESS RELEASE

published on 03/17/2025 at 07:00, 8 months 19 days ago

Biophytis revolutionizes sarcopenia
Biophytis announces groundbreaking results from SARA-INT Phase II trial for BIO101 in sarcopenia, confirming Phase 3 readiness. Publication in JCSM highlights efficacy and safety

Biophytis Clinical Trial Sarcopenia Phase II SARA-INT
BRIEF

published on 03/06/2025 at 07:05, 8 months 30 days ago

Biophytis to Attend BIO-Europe Spring 2025 in Milan

Biophytis Biotechnology Drug Development BIO-Europe 2025 Aging Diseases

Accesswire

Published on 12/05/2025 at 15:25, 15 minutes ago

Usha Resources Provides Corporate Updates
Published on 12/05/2025 at 15:00, 40 minutes ago

Calidi Biotherapeutics and Nova Minerals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Published on 12/05/2025 at 14:00, 1 hour 40 minutes ago

Ocean Power Technologies Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 14:00, 1 hour 40 minutes ago

Bonk, Inc. Highlights Major Ecosystem Milestone: Launch of Regulated BONK ETP on SIX Swiss Exchange
Published on 12/05/2025 at 02:35, 13 hours 5 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 15:35, 4 minutes ago

Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Published on 12/05/2025 at 15:05, 34 minutes ago

Seegene Establishes French Subsidiary to Expand European Footprint
Published on 12/05/2025 at 14:22, 1 hour 17 minutes ago

EQS-Adhoc: Jungheinrich AG: Jungheinrich expects to complete sale of its Russian subsidiary in 2026 and adjusts forecast for the 2025 financial year
Published on 12/05/2025 at 14:16, 1 hour 23 minutes ago

Advanced Blockchain AG: Successful Completion of Token Generation Event of Portfolio company Talisman
Published on 12/05/2025 at 14:10, 1 hour 29 minutes ago

The Kingdom of Saudi Arabia Launches a New Official Platform, "Saudi Properties", Ahead of the Non-Saudi Property Ownership Law

Les Echos

Published on 12/05/2025 at 15:10, 29 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 08:45, 6 hours 55 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 21 hours 40 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 21 hours 55 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 21 hours 56 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution

View all LES ECHOS COMFI WIRE